Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright ...

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a ...

Los Angeles Chargers head coach Jim Harbaugh truly lives by "faith, family, football," and he called it "inspiring" to see other NFL stars so open about doing the same.

Invivyd's bid to expand Pemgarda's EUA for COVID-19 treatment was denied by the FDA. The company will share new data on ...

Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent ...

Los Angeles Chargers head coach Jim Harbaugh shared his view on the controversial tush push, saying teams either have to "get ...

We recently compiled a list of the 10 Micro and Small-Cap Firms Drive Year-to-Date Gains. In this article, we are going to ...

H.C. Wainwright maintains a Buy rating on Invivyd (IVVD) with a $10 price target after the FDA rejected its submission to expand Pemgarda’s ...

In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Invivyd (IVVD – Research Report), with a price ...

The commercial-stage biopharmaceutical company said its request to expand the existing emergency use authorization of the drug, also called pemivibart, to treat mild-to-moderate Covid-19 in more ...

Yahoo Sports NFL analyst Nate Tice chats with the Los Angeles head coach about how the Chargers star quarterback fits into ...